Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
"The program is designed to reduce cost uncertainty and help people start and stay on [the] FDA-approved obesity treatment," the company said
Altimmune Presents Data from Phase 2 MOMENTUM Trial of Pemvidutide in Obesity during Oral Presentation at the American Diabetes Association
Improving metabolic health whether through lifestyle changes, medical therapy, or weight loss may help restore healthier reproductive hormone signaling
A 2019 clinical study found 300 mg daily oral glutathione prevented NASH progression from NAFLD
US$ 27.60
US$ 25.15
US$ 21.11
US$ 28.94
US$ 22.63
US$ 29.38
US$ 28.09
US$ 23.78
